Clinical Trials · NCT03668470
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Hospices Civils de Lyon
- Enrollment
- 45
- Start date
- Jan 2019
- Locations
- 7 sites, France
- Primary endpoint
- HbA1c level